SANTHERA PHARMACEUTICALS HOLDING AG

Transcripts Santhera Pharmaceuticals Holding AG

Equities

SANN

CH1276028821

Market Closed - Swiss Exchange Other stock markets 11:30:42 2024-05-31 am EDT			5-day change	1st Jan Change
9.87 ^CHF	-1.30%		+5.45%	+0.61%

Apr. 25	Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024
Apr. 25	Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024	Apr. 25
Transcript : Santhera Pharmaceuticals Holding AG, H1 2023 Earnings Call, Sep 07, 2023	23-09-07
Transcript : Santhera Pharmaceuticals Holding AG - Special Call	23-06-20
Transcript : Santhera Pharmaceuticals Holding AG, 2022 Earnings Call, Apr 27, 2023	23-04-27
Transcript : Santhera Pharmaceuticals Holding AG, H1 2022 Earnings Call, Nov 07, 2022	22-11-07
Transcript : Santhera Pharmaceuticals Holding AG, 2021 Earnings Call, Jun 10, 2022	22-06-10
Transcript : Santhera Pharmaceuticals Holding AG - Special Call	21-12-08
Transcript : Santhera Pharmaceuticals Holding AG, H1 2021 Earnings Call, Sep 22, 2021	21-09-22
Transcript : Santhera Pharmaceuticals Holding AG - Special Call	21-06-01
Transcript : Santhera Pharmaceuticals Holding AG, 2020 Earnings Call, Apr 29, 2021	21-04-29
Transcript : Santhera Pharmaceuticals Holding AG - Special Call	20-10-06
Transcript : Santhera Pharmaceuticals Holding AG, H1 2020 Earnings Call, Sep 08, 2020	20-09-08
Transcript : Santhera Pharmaceuticals Holding AG - Special Call	20-05-29
Transcript : Santhera Pharmaceuticals Holding AG, 2019 Earnings Call, Mar 24, 2020	20-03-24
Santhera Pharmaceuticals Holding AG Provides Earnings Guidance for the Full Year 2019	19-09-03	CI
Santhera Pharmaceuticals Reports Preliminary Unaudited Revenues for the Year 2017; Provides Earnings Guidance for the Year 2017 and Sales Guidance for the Year 2018	18-01-29	CI
Santhera Pharmaceuticals Announces Preliminary Revenue Results for the Full Year 2016; Provides Earnings Guidance for the Full Year 2016 and Sales Guidance for the Full Year 2017	17-01-30	CI
Santhera Pharmaceuticals Holding AG Announces Preliminary Unaudited Revenue Results for the Second Half and Full Year of 2016; Provides Earnings Guidance for the Year 2016 and Revenue Guidance for the Year 2017	17-01-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
SANN Stock
News Santhera Pharmaceuticals Holding AG
Transcripts

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer